Two-dose recommendation for Human Papillomavirus vaccine can be extended up to 18 years – updated evidence from Indian follow-up cohort study

Earlier publication from the ongoing multi-centric study of the International Agency for Research on Cancer to evaluate less than three doses of the quadrivalent Human Papillomavirus (HPV) vaccine in India amongst unmarried girls demonstrated non-inferior total antibody titres, neutralizing antibody...

Descripción completa

Detalles Bibliográficos
Autores principales: Basu, Partha, Muwonge, Richard, Bhatla, Neerja, Nene, Bhagwan M., Joshi, Smita, Esmy, Pulikottil O., Poli, Usha Rani Reddy, Joshi, Geeta, Verma, Yogesh, Zomawia, Eric, Shastri, Surendra S., Pimple, Sharmila, Anantharaman, Devasena, Prabhu, Priya R., Hingmire, Sanjay, Sauvaget, Catherine, Lucas, Eric, Pawlita, Michael, Gheit, Tarik, Jayant, Kasturi, Malvi, Sylla G., Siddiqi, Maqsood, Michel, Angelika, Butt, Julia, Sankaran, Subha, Rameshwari Ammal Kannan, Thiraviam Pillai, Varghese, Rintu, Divate, Uma, Willhauck-Fleckenstein, Martina, Waterboer, Tim, Müller, Martin, Sehr, Peter, Vashist, Shachi, Mishra, Gauravi, Jadhav, Radhika, Thorat, Ranjit, Tommasino, Massimo, Pillai, M. Radhakrishna, Sankaranarayanan, Rengaswamy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378832/
https://www.ncbi.nlm.nih.gov/pubmed/30711698
http://dx.doi.org/10.1016/j.pvr.2019.01.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378832/
https://www.ncbi.nlm.nih.gov/pubmed/30711698
http://dx.doi.org/10.1016/j.pvr.2019.01.004

Ejemplares similares